CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.24% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
36.565
1.39%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 15:30

Mon - Thu: 07:00 - 11:00 11:03 - 15:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.095
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.017952 %
Charges from full value of position ($-3.41)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.017952%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.004271 %
Charges from full value of position ($-0.81)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.004271%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5.00%
Stock exchange Germany
Commission on trade 0%

Key Stats
Prev. Close 37.07
Open 37.145
1-Year Change -0.79%
Day's Range 36.4 - 37.145
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 15, 2025 37.070 -0.275 -0.74% 37.345 37.615 36.960
Apr 14, 2025 36.990 0.235 0.64% 36.755 37.190 36.560
Apr 11, 2025 36.405 0.475 1.32% 35.930 36.535 35.430
Apr 10, 2025 35.365 -1.220 -3.33% 36.585 36.845 35.365
Apr 9, 2025 35.565 0.290 0.82% 35.275 36.320 35.275
Apr 8, 2025 36.730 0.500 1.38% 36.230 37.130 35.965
Apr 7, 2025 35.905 -0.240 -0.66% 36.145 37.605 34.025
Apr 4, 2025 35.395 -1.005 -2.76% 36.400 36.555 35.290
Apr 3, 2025 36.025 -0.450 -1.23% 36.475 37.460 35.990
Apr 2, 2025 36.825 0.660 1.82% 36.165 36.890 36.165
Apr 1, 2025 36.965 -0.370 -0.99% 37.335 37.365 36.790
Mar 31, 2025 36.615 0.200 0.55% 36.415 36.660 36.290
Mar 28, 2025 36.775 0.170 0.46% 36.605 37.085 36.605
Mar 27, 2025 36.805 0.240 0.66% 36.565 36.905 36.430
Mar 26, 2025 36.665 -0.115 -0.31% 36.780 36.825 36.390
Mar 25, 2025 36.780 -0.175 -0.47% 36.955 37.135 36.680
Mar 24, 2025 36.815 0.125 0.34% 36.690 37.010 36.460
Mar 21, 2025 36.580 0.615 1.71% 35.965 36.610 35.340
Mar 20, 2025 36.265 -0.165 -0.45% 36.430 36.685 36.165
Mar 19, 2025 36.400 0.210 0.58% 36.190 36.545 36.150

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Qiagen Company profile

About Qiagen NV

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Qiagen NV revenues increased 20% to $2.25B. Net income increased 43% to $512.6M. Revenues reflect Consumables and Related Revenues segment increase of 23% to $1.99B, Instrumentation segment increase of 4% to $265.3M, United States segment increase of 25% to $909.7M, Europe & Middle East & Afric segment increase of 19% to $814.4M. Net income benefited from Restructuring decrease of 81% to $27.8M (expense).

Equity composition

1/2017, Shares Consolidation (Factor: 0.96296).

Industry: Biotechnology & Medical Research (NEC)

Hulsterweg 82
VENLO
LIMBURG 5912 PL
NL

People also watch

US100

18,500.50 Price
-1.690% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0012%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

84,458.05 Price
+0.450% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

XRP/USD

2.10 Price
-0.870% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01046

Gold

3,312.65 Price
+2.610% 1D Chg, %
Long position overnight fee -0.0175%
Short position overnight fee 0.0093%
Overnight fee time 21:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 720,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading